06 May 2025
|
Audited Results & Final Dividend |
- |
27 Jan 2025
|
Quarterly Results |
- |
23 Oct 2024
|
Quarterly Results |
- |
13 Aug 2024
|
Quarterly Results |
- |
08 May 2024
|
Audited Results & Final Dividend |
- |
29 Jan 2024
|
Quarterly Results |
- |
09 Nov 2023
|
Quarterly Results |
- |
28 Jul 2023
|
Quarterly Results & Buy Back |
- |
05 May 2023
|
Audited Results & Final Dividend |
- |
08 Feb 2023
|
Quarterly Results |
- |
09 Nov 2022
|
Quarterly Results |
- |
29 Jul 2022
|
Quarterly Results |
- |
14 Jul 2022
|
To consider raising of funds |
- |
26 May 2022
|
Audited Results & Final Dividend |
- |
10 Feb 2022
|
Quarterly Results |
- |
11 Nov 2021
|
Quarterly Results |
- |
06 Aug 2021
|
Quarterly Results |
- |
13 May 2021
|
Audited Results & Final Dividend |
- |
11 Feb 2021
|
Quarterly Results |
- |
28 Oct 2020
|
Quarterly Results |
- |
30 Jul 2020
|
Quarterly Results |
- |
11 May 2020
|
Audited Results & Final Dividend |
- |
18 Mar 2020
|
Interim Dividend |
- |
04 Feb 2020
|
Quarterly Results |
- |
25 Oct 2019
|
Preferential Issue of shares |
- |
21 Oct 2019
|
Quarterly Results |
- |
30 Jul 2019
|
Quarterly Results |
- |
26 Apr 2019
|
Audited Results & Dividend |
- |
28 Jan 2019
|
Quarterly Results |
- |
18 Dec 2018
|
Others |
To consider amendment to the terms of issue of Non-convertible Debentures issued vide Information Memorandum dated November 15, 2018 and November 28, 2018. |
25 Oct 2018
|
Quarterly Results |
- |
30 Jul 2018
|
Quarterly Results |
- |
28 May 2018
|
Audited Results & Dividend |
- |
02 Apr 2018
|
Others |
Setting-up wholly owned subsidiaries of the company to commence business of Merchant banking and Asset Management. |
30 Jan 2018
|
Quarterly Results |
- |
06 Nov 2017
|
Quarterly Results |
- |
12 Oct 2017
|
Raising of funds & SoA |
- |
01 Aug 2017
|
Quarterly Results |
- |
12 May 2017
|
Audited Results & Others |
To consider Raising of funds |
13 Feb 2017
|
Quarterly Results |
- |
27 Oct 2016
|
Quarterly Results |
- |
25 Aug 2016
|
Others |
Approve the issue on private placement basis of secured non-convertible debentures aggregating to Rs. 80 crores in one or more issues from time to time. |
01 Aug 2016
|
Quarterly Results |
- |
10 Jun 2016
|
Others |
To approve the issue on private placement basis of Secured Non-Convertible Debentures amounting upto Rs. 300 crores. |
16 May 2016
|
Audited Results |
- |
09 Mar 2016
|
Interim Dividend |
- |
29 Feb 2016
|
Others |
To consider and approve the issue on private placement basis of secured non-convertible debentures amounting upto Rs 1000 crores in one or more tranches from time to time. |
08 Feb 2016
|
Quarterly Results |
- |
02 Nov 2015
|
Quarterly Results |
- |
06 Aug 2015
|
Quarterly Results |
- |
07 May 2015
|
Audited Results & Dividend |
- |
09 Feb 2015
|
Quarterly Results |
- |
21 Oct 2014
|
Quarterly Results |
- |
06 Aug 2014
|
Quarterly Results |
- |
05 May 2014
|
Audited Results & Dividend |
- |
30 Jan 2014
|
Quarterly Results |
- |
23 Oct 2013
|
Quarterly Results |
- |
25 Jul 2013
|
Quarterly Results |
- |
03 May 2013
|
Audited Results & Dividend |
- |
11 Feb 2013
|
Quarterly Results |
- |
05 Nov 2012
|
Quarterly Results |
- |
14 Aug 2012
|
Quarterly Results |
- |
03 May 2012
|
Audited Results & Dividend |
- |
02 Apr 2012
|
Change in name of the Company |
To change the name of the Company from Piramal Healthcare Limited to Piramal Enterprises Limited or such other name as maybe approved by the Registrar of Companies / other statutory authorities. |
02 Feb 2012
|
Quarterly Results |
- |
20 Oct 2011
|
Quarterly Results |
- |
02 Aug 2011
|
Quarterly Results |
- |
06 May 2011
|
Audited Results & Special Dividend |
For considering a proposal for Demerger of the New Chemical Entity (NCE) Research Unit of Piramal Life Sciences Ltd ('PLSL') into the Company. The Company has a 17.88% equity stake in PLSL. |
11 Feb 2011
|
Quarterly Results |
- |
22 Oct 2010
|
Qtrly Results, Dividend & Buy Back |
- |
10 Aug 2010
|
Quarterly Results |
- |
21 May 2010
|
Others |
The Board has granted its approval to the Company entering into a definitive agreement with Abbott (Abbott of Illinois, USA, for Abbott to acquire Piramals Domestic Formulations business. |
07 May 2010
|
Audited Results & Dividend |
(Revised) |
21 Jan 2010
|
Quarterly Results |
- |
03 Dec 2009
|
Raising of funds by issue of Securities |
For raising funds upto an amount of Rs. 1000 Crs through an issue of Equity / Equity-linked Securities, subject to requisite approvals. |
22 Oct 2009
|
Quarterly Results |
- |
22 Jul 2009
|
Quarterly Results |
- |
24 Apr 2009
|
Audited Results & Dividend |
- |
22 Jan 2009
|
Quarterly Results |
- |
22 Oct 2008
|
Quarterly Results |
- |
24 Jul 2008
|
Quarterly Results |
- |
24 Apr 2008
|
Audited Results |
- |
18 Jan 2008
|
Quarterly Results |
- |
25 Oct 2007
|
Quarterly Results |
- |
31 Aug 2007
|
Scheme of Arrangement |
- |
25 Jul 2007
|
Quarterly Results |
- |
26 Apr 2007
|
Audited Results |
- |
15 Mar 2007
|
Interim Dividend |
- |
18 Jan 2007
|
Quarterly Results |
- |
18 Oct 2006
|
Quarterly & Half Yearly Results |
- |
20 Jul 2006
|
Quarterly Results |
- |
25 Apr 2006
|
Accounts & Raising of funds |
The Board will also discuss raising of resources through appropriate securities. |
19 Jan 2006
|
Quarterly Results |
- |
20 Oct 2005
|
Quarterly Results |
- |
29 Jul 2005
|
Quarterly Results & Accounts |
- |
26 Apr 2005
|
Accounts |
- |
12 Mar 2005
|
Others |
To consider various options to raise funds domestically/internationally from existing and/or new investors. |
21 Jan 2005
|
Quarterly Results |
- |
17 Dec 2004
|
Others |
Approved the acquisition of the global inhalation Anaesthetics (IA) business of Rhodia Organique Fine Ltd (Rhodia), U.K., |
21 Oct 2004
|
Quarterly Results |
- |